[Effects of mild moxibustion on the uterine microcirculation in patients of primary dysmenorrhea].

Zhongguo Zhen Jiu

School of Acupuncture-Moxibustion and Tuina, Chengdu University of TCM, Chengdu 610072, Sichuan Province, China.

Published: July 2018

Objective: To observe the effects of mild moxibustion on the uterine microcirculation in patients of primary dysmenorrhea (PD) and explore the potential mechanism of mild moxibustion in the treatment of PD.

Methods: A total of 30 patients were randomized into a treatment group and a waiting list group, 15 cases in each one. Additionally, 15 healthy people were collected in the healthy group. In the treatment group, the mild moxibustion was used at Guanyuan (CV 4) and Sanyinjiao (SP 6). The treatment was given once a day since 5 to 7 days before menstruation until menses, 20 min each time. The treatment lasted for 3 menstrual cycles. No any intervention was provided in the waiting list group and the healthy group. The three-dimensional Doppler ultrasound test was adopted to observe the changes of the relevant indexes of uterine arterial blood, such as the systolic velocity (Vs), the diastolic velocity (Vd), the mean velocity (Vm), peak systolic velocity/end diastolic velocity (S/D), pulsatility index (PI) and the resistance index (RI) before treatment and at the end of 3-menstrual-cycle treatment.

Results: Before treatment, as compared with the healthy group, Vs, Vd and Vm reduced in the treatment group and the waiting list group, S/D, PI and RI increased in the treatment group (all <0.05). The differences were not significant in S/D, PI and RI between the waiting list group and the healthy group (all >0.05). After treatment for 3 menstrual cycles, Vs, Vd and Vm increased in the treatment group (all <0.05), S/D, PI and RI reduced (all <0.05). The difference was not significant in every index before and after trial in the waiting list group and the healthy group (all >0.05). After treatment, Vs, Vd and Vm in the treatment group were higher than those in the waiting list group (all <0.05) and the difference was not significant as compared with those in the healthy group (all >0.05). S/D, PI and RI in the treatment group were lower than those in the waiting list group and the healthy group (all <0.05).

Conclusion: The mild moxibustion remarkably improves the uterine microcirculation in PD patients, which is achieved possibly by increasing blood velocity and reducing vascular resistance.

Download full-text PDF

Source
http://dx.doi.org/10.13703/j.0255-2930.2018.07.009DOI Listing

Publication Analysis

Top Keywords

treatment group
20
mild moxibustion
16
waiting list
12
list group
12
healthy group
12
treatment
11
group
11
moxibustion uterine
8
uterine microcirculation
8
microcirculation patients
8

Similar Publications

Background: Animated short videos used to explain a concept or project are often called animated explainer videos (AEVs). AEVs can supplement or provide an alternative to participant information sheets as a means of giving information about clinical research to potential participants. Current use of AEVs tends to focus on the specifics of a particular trial, yet there are many common aspects of clinical research regardless of the interventions being investigated that can be poorly covered in current trial materials.

View Article and Find Full Text PDF

Background: Drug use trends change rapidly among youth, leaving intervention experts struggling to respond promptly. Delays in responses can lead to preventable morbidity and mortality. The COVID-19 pandemic underscored the need for implementation science to facilitate rapid, equitable responses using existing treatment and prevention efforts.

View Article and Find Full Text PDF

Multiplexed assays of variant effect (MAVEs) are a critical tool for researchers and clinicians to understand genetic variants. Here we describe the 2024 update to MaveDB ( https://www.mavedb.

View Article and Find Full Text PDF

Introduction: Doxorubicin is a chemotherapeutic drug used to treat various cancers. Exercise training (ET) can attenuate some cardiotoxic effects of doxorubicin (DOX) in tumor-free animals. However, the ET effects on cardiac function and glucose metabolism in DOX-treated breast cancer models remain unclear.

View Article and Find Full Text PDF

Study on the effects of Mogroside V in inhibiting NLRP3-mediated granulosa cell pyroptosis and insulin resistance to improve PCOS.

J Ovarian Res

January 2025

The First Affiliated Hospital, Gynecology&Obstetrics and Reproductive Medical Center, School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.

Objective: Polycystic Ovary Syndrome (PCOS) is a prevalent endocrinopathy in reproductive-aged women, contributing to 75% of infertility cases due to ovulatory dysfunction. The condition poses significant health and psychological challenges, making the study of its pathogenesis and treatment a research priority. This study investigates the effects of Mogroside V (MV) on PCOS, focusing on its anti-inflammatory and anti-insulin resistance properties.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!